COPD — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Consider in selected patients after ruling out contraindications and nonpharmacologic measures
The best answer is “Consider in selected patients after ruling out contraindications and nonpharmacologic measures”. Consider in selected patients after ruling out contraindications and nonpharmacologic measures is supported by the decisive clinical findings and the cited specialist guidance. The alternatives remain plausible in related respiratory presentations but do not fit the stated threshold, sequence or physiology. The remaining choices—“supported for all COPD, after specialist assessment, with clinical reassessment”, “unsuitable in all patients, with clinical reassessment, within a respiratory pathway”, “Replace inhaled therapy, after safety review, within a respiratory pathway, after safety review”, “Use for 12 months in all, after safety review, after specialist assessment”—are credible in related respiratory presentations, but each addresses a different diagnostic, staging or management decision and does not fit the decisive findings and pathway position in this stem.
Reference: NICE NG115 chronic obstructive pulmonary disease: https://www.nice.org.uk/guidance/ng115/chapter/Recommendations